How much does Finerenone cost per box and reference prices in various regions
Finerenone is a new type of non-steroidal selective mineral corticoid receptor antagonist, mainly used in patients with chronic kidney disease and type 2 diabetes to slow down the deterioration of renal function and the risk of cardiovascular events. At present, fenelidone has been launched in China and has been included in the medical insurance system, which means that patients can purchase it in regular domestic hospital pharmacies and enjoy a certain percentage of medical insurance reimbursement. Specific reimbursement policies and personal burdens vary by region. Patients are advised to consult their local hospital or medical insurance department for accurate information before taking medication.
In the domestic market, the price of fenelidone is relatively moderate, with the price of each box being around several thousand yuan. Since it has been included in medical insurance, eligible patients can reduce their financial burden through medical insurance reimbursement during long-term use. This is particularly important for patients with chronic diseases, as these drugs often require continued use to maintain stable efficacy and reduce cardiorenal risks.
In foreign markets, fenelidone is available as both original and generic drugs. Original drugs mainly include the Japanese version and the American version. The price is relatively high, ranging from more than 2,000 to more than 9,000 yuan, depending on the sales area and packaging specifications. In comparison, the price of generic drugs is more affordable. For example, each box of the Laos Lucius version of generic drugs only costs a few hundred yuan. At the same time, the drug ingredients are basically the same as the original drugs, providing patients with an economically feasible choice.
Overall, there are significant price differences for fenelidone around the world. Domestic drugs are already on the market and included in medical insurance, providing patients with affordable access to medication, while generic drugs in overseas markets further reduce the cost of cross-border drug purchase. When choosing purchasing channels, patients should comprehensively consider price, drug sources, drug safety, and medical insurance policies to ensure safe and economical treatment results.
Reference link:https://www.drugs.com
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)